Regional nodal irradiation might not improve locoregional recurrence-free survival in ypN0 breast cancer patients undergoing neoadjuvant chemotherapy
Background The role of regional nodal irradiation (RNI) after neoadjuvant chemotherapy (NAC) in patients with clinically node-positive (cN1) breast cancer remains controversial among those achieving nodal pathological complete response (ypN0). This multicenter study evaluated the impact of adjuvant RNI on survival outcomes in a real-world cohort. Methods Patients with invasive breast cancer and clinically positive axillary nodes treated with NAC were identified and categorized according to receipt of adjuvant RNI. Propensity score matching (1:1) was performed to balance baseline characteristics. Primary endpoints were 5-yr axillary recurrence-free survival (ARFS) and 5-yr locoregional recurrence-free survival (LRRFS). Results After propensity score matching, 842 patients (421 per group) were analyzed. RNI was not associated with improved 5-yr ARFS (94.9% vs. 95.8%, p=0.546) or 5-yr LRRFS (95.2% vs. 95.6%, p=0.977) when compared to no RNI. Disease-free (p=0.0003) and distant metastases-free (p=0.0002) survival rates were lower with RNI than without RNI, suggesting that patients undergoing RNI were affected by a worst disease. Multivariable analysis confirmed that RNI was not independently associated with ARFS or LRRFS, whereas residual nodal disease (ypN+) was the strongest predictor of poorer ARFS (HR 3.28, p=0.02) and LRRFS (HR 4.21, p=0.008). Conclusions Adjuvant RNI might not improve axillary or locoregional outcomes after NAC in cN+ breast cancer patients, particularly among those achieving ypN0 status. Post-treatment nodal status is strongly associated to locoregional prognosis, supporting consideration of RNI de-escalation in selected ypN0 patients.
Authors
- Marta Sevieri (ORCID: https://orcid.org/0000-0003-2017-641X)
- Chiara Annunziata Pasqualina Anghelone
- Chiara Listorti (ORCID: https://orcid.org/0000-0003-4553-0817)
- Giulia Armatura (ORCID: https://orcid.org/0000-0002-8536-7551)
- Daniela Bossi (ORCID: https://orcid.org/0000-0002-7917-0437)
- Annalisa Curcio (ORCID: https://orcid.org/0000-0002-0091-8247)
- Marco Lunghi (ORCID: https://orcid.org/0000-0001-5747-4491)
- Secondo Folli (ORCID: https://orcid.org/0000-0003-3465-3010)
- Simona Papi
- Andrea Papadia (ORCID: https://orcid.org/0000-0002-4909-9588)
- Valentina Zanella
- Maria Luisa Gasparri (ORCID: https://orcid.org/0000-0002-9482-9527)
- Fabio Corsi (ORCID: https://orcid.org/0000-0002-6469-4086)
- Daniela Tognali
- Sara Albasini (ORCID: https://orcid.org/0000-0002-8764-3919)
- Anna Pertusati
- Paola Canino
- Luca Sorrentino (ORCID: https://orcid.org/0000-0002-3963-2385)
- Francesca Angela Rovera (ORCID: https://orcid.org/0000-0001-8172-3339)
- Stefano Mancini (ORCID: https://orcid.org/0000-0002-3173-1450)
- Angelica Della Valle (ORCID: https://orcid.org/0000-0002-2411-2707)
- Corrado Chiappa (ORCID: https://orcid.org/0000-0002-6153-3156)
- Silvia Segattini
- Giulia Pappalettera (ORCID: https://orcid.org/0009-0008-7685-4607)
- Carlo Morasso (ORCID: https://orcid.org/0000-0001-9185-0198)
- Beatrice Bignami
- Seyedeh Negin Sadat Madarshahi (ORCID: https://orcid.org/0009-0005-1656-7452)
- Christoph Mayr
Institutions
- University of Insubria (IT)
- University of Milan (IT)
- Ospedale regionale di Lugano (CH)
- Ospedale di Bolzano (IT)
- Istituti Clinici Scientifici Maugeri (IT)
- Azienda Unità Sanitaria Locale Della Romagna (IT)
- Azienda Ospedaliero-Universitaria di Modena (IT)
- Ospedale “M. Bufalini” di Cesena (IT)
- Ospedale G.B. Morgagni - L.Pierantoni (IT)
- Policlinico San Matteo Fondazione (IT)
- Fondazione IRCCS Istituto Nazionale dei Tumori (IT)
- ASST Fatebenefratelli Sacco (IT)
- Aziende Socio Sanitarie Territoriale dei Sette Laghi (IT)
- Istituto Oncologico della Svizzera Italiana (CH)
- Azienda Sanitaria dell'Alto Adige (IT)
- Università della Svizzera italiana (CH)
Publication Details
- Journal
- The Breast
- Published
- 2026-11-19
- DOI
- https://doi.org/10.1016/j.breast.2026.104965
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00